- Home
- LPTX vs GORV Comparison
LPTX vs GORV Comparison
Compare LPTX & GORV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTX
- GORV
- Stock Information
- Founded
- LPTX 2011
- GORV 1976
- Country
- LPTX United States
- GORV United States
- Employees
- LPTX N/A
- GORV N/A
- Industry
- LPTX Biotechnology: Biological Products (No Diagnostic Substances)
- GORV Retail-Auto Dealers and Gas Stations
- Sector
- LPTX Health Care
- GORV Consumer Discretionary
- Exchange
- LPTX Nasdaq
- GORV Nasdaq
- Market Cap
- LPTX 11.1M
- GORV 10.6M
- IPO Year
- LPTX N/A
- GORV 2015
- Fundamental
- Price
- LPTX $0.75
- GORV $2.52
- Analyst Decision
- LPTX Hold
- GORV
- Analyst Count
- LPTX 1
- GORV 0
- Target Price
- LPTX N/A
- GORV N/A
- AVG Volume (30 Days)
- LPTX 7.6M
- GORV 1.7M
- Earning Date
- LPTX 11-12-2025
- GORV 11-17-2025
- Dividend Yield
- LPTX N/A
- GORV N/A
- EPS Growth
- LPTX N/A
- GORV N/A
- EPS
- LPTX N/A
- GORV N/A
- Revenue
- LPTX N/A
- GORV $662,952,000.00
- Revenue This Year
- LPTX N/A
- GORV $15.65
- Revenue Next Year
- LPTX N/A
- GORV $20.54
- P/E Ratio
- LPTX N/A
- GORV N/A
- Revenue Growth
- LPTX N/A
- GORV N/A
- 52 Week Low
- LPTX $0.22
- GORV $2.04
- 52 Week High
- LPTX $4.79
- GORV $58.80
- Technical
- Relative Strength Index (RSI)
- LPTX 63.63
- GORV 46.20
- Support Level
- LPTX $0.46
- GORV $2.35
- Resistance Level
- LPTX $0.98
- GORV $3.10
- Average True Range (ATR)
- LPTX 0.11
- GORV 0.25
- MACD
- LPTX 0.03
- GORV 0.10
- Stochastic Oscillator
- LPTX 51.58
- GORV 46.30
About LPTX Leap Therapeutics Inc.
Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, and harnessing the immune system to attack cancer cells. The company's key clinical-stage drug candidate is sirexatamab (DKN-01), which targets Dickkopf-related protein 1 (DKK1) and is being studied in a clinical trial in patients with colorectal cancer. In addition, it also has a preclinical program to develop a proprietary monoclonal antibody, called FL-501 which works by inhibiting the GDF-15 protein.
About GORV Lazydays Holdings Inc.
Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.